F railty-adjusted therapy i n T ransplant N on- E ligible patient s with newly diagno s ed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III trial.

Amy Beth Coulson Kara-Louise RoyleCharlotte PawlynDavid A CairnsAnna HockadayJennifer BirdStella BowcockMartin KaiserRuth de TuteNeil RabinKevin BoydJohn JonesChristopher ParrishHayley GardnerDavid MeadsBryony DawkinsCatherine OlivierRowena HendersonPhillip BestRoger OwenMatthew JennerBhuvan KishoreMark DraysonGraham JacksonGordon Cook

Published in: BMJ open (2022)

ISRCTN17973108, NCT03720041.

Keyphrases

phase iii
open label
clinical trial
multiple myeloma
double blind
placebo controlled
phase ii
study protocol
emergency department
body composition
case report
physical activity
randomized controlled trial
newly diagnosed
stem cells
magnetic resonance imaging
mesenchymal stem cells